Tumour Immunology

LAP targeting reduces tolerogenic cells in cancer

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Gabriely, G. et al. Targeting latency-associated peptide promotes antitumor immunity. Sci. Immunol. 2, eaaj1738 (2017)

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Flemming, A. LAP targeting reduces tolerogenic cells in cancer. Nat Rev Immunol 17, 402–403 (2017). https://doi.org/10.1038/nri.2017.65

Download citation

Search

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing